On the road to structure-based development of anti-virulence therapeutics targeting the type III secretion system injectisome
BJE Lyons, NCJ Strynadka - Medchemcomm, 2019 - pubs.rsc.org
The type III secretion system injectisome is a syringe-like multimembrane spanning
nanomachine that is essential to the pathogenicity but not viability of many clinically relevant …
nanomachine that is essential to the pathogenicity but not viability of many clinically relevant …
On the road to structure-based development of anti-virulence therapeutics targeting the type III secretion system injectisome
BJE Lyons, NCJ Strynadka - MedChemComm, 2019 - pubmed.ncbi.nlm.nih.gov
The type III secretion system injectisome is a syringe-like multimembrane spanning
nanomachine that is essential to the pathogenicity but not viability of many clinically relevant …
nanomachine that is essential to the pathogenicity but not viability of many clinically relevant …
On the road to structure-based development of anti-virulence therapeutics targeting the type III secretion system injectisome.
BJE Lyons, NCJ Strynadka - Medchemcomm, 2019 - europepmc.org
The type III secretion system injectisome is a syringe-like multimembrane spanning
nanomachine that is essential to the pathogenicity but not viability of many clinically relevant …
nanomachine that is essential to the pathogenicity but not viability of many clinically relevant …
[HTML][HTML] On the road to structure-based development of anti-virulence therapeutics targeting the type III secretion system injectisome
BJE Lyons, NCJ Strynadka - MedChemComm, 2019 - ncbi.nlm.nih.gov
The type III secretion system injectisome is a syringe-like multimembrane spanning
nanomachine that is essential to the pathogenicity but not viability of many clinically relevant …
nanomachine that is essential to the pathogenicity but not viability of many clinically relevant …